Mr. Stephen Davis reports

FREQUENCY EXCHANGE CLOSES 2ND TRANCHE OF PRIVATE PLACEMENT

Further to its news releases dated April 17, 2024, and April 30, 2024, Frequency Exchange Corp. has closed the second tranche of its private placement.

The second tranche of the private placement was for a total of 2,353,846 units at a price of 15 cents per unit for proceeds of $353,076. Each unit consisted of one common share and one common share purchase warrant, having an exercise price of 25 cents per warrant and a term of 24 month from the date of issuance. The warrants are subject to an acceleration clause, whereby, if the volume-weighted average trading price of the common shares on the TSX Ventures Exchange is at least 40 cents per common share for any period of 10 consecutive trading days, the company may, at its sole option, accelerate the expiry date of warrants to the date that is not less than 21 days following the date upon which notice of the accelerated expiry date is provided by the company by way of news release.

All securities issued in connection with the second tranche of the private placement are subject to a statutory hold period expiring Dec. 1, 2024.

Due to increased demand, the company has increased the size of the private placement from $500,000 to $1-million. The private placement and the increase are subject to TSX-V final approval.

About Frequency Exchange Corp.

Based in British Columbia, Canada, Frequency Exchange is focused on the development and global commercialization of Nikki, a personal frequency delivery system. Nikki means "victor of the people" as it helps all walks of life. Fremedica has created specialized Lyme support program designed to help people struggling with Lyme disease, along with several wellness programs to assist with issues around sleep, pain, energy and immunity, to name a few. The categories of frequencies continue to grow. This wearable technology, combined with these frequency-based wellness programs, is the result of years of development and experimentation with advanced bioenergetic technology.

We seek Safe Harbor.